Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy.
Béténé A Dooko C, De Wit S, Neuhaus J, Palfreeman A, Pepe R, Pankow JS, Neaton JD; INSIGHT SMART; ESPRIT Study Groups. Béténé A Dooko C, et al. Among authors: palfreeman a. J Acquir Immune Defic Syndr. 2014 Dec 15;67(5):538-46. doi: 10.1097/QAI.0000000000000354. J Acquir Immune Defic Syndr. 2014. PMID: 25393940 Free PMC article.
Inflammation-Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It?
Hart BB, Nordell AD, Okulicz JF, Palfreeman A, Horban A, Kedem E, Neuhaus J, Jacobs DR Jr, Duprez DA, Neaton JD; INSIGHT SMART and ESPRIT Groups. Hart BB, et al. Among authors: palfreeman a. J Acquir Immune Defic Syndr. 2018 Jan 1;77(1):1-7. doi: 10.1097/QAI.0000000000001554. J Acquir Immune Defic Syndr. 2018. PMID: 28991883 Free PMC article. Clinical Trial.
Immediate Antiretroviral Therapy Reduces Risk of Infection-Related Cancer During Early HIV Infection.
Borges ÁH, Neuhaus J, Babiker AG, Henry K, Jain MK, Palfreeman A, Mugyenyi P, Domingo P, Hoffmann C, Read TR, Pujari S, Meulbroek M, Johnson M, Wilkin T, Mitsuyasu R; INSIGHT START Study Group. Borges ÁH, et al. Among authors: palfreeman a. Clin Infect Dis. 2016 Dec 15;63(12):1668-1676. doi: 10.1093/cid/ciw621. Epub 2016 Sep 8. Clin Infect Dis. 2016. PMID: 27609756 Free PMC article. Clinical Trial.
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study.
Strategies for Management of Antiretroviral Therapy (SMART) Study Group; Emery S, Neuhaus JA, Phillips AN, Babiker A, Cohen CJ, Gatell JM, Girard PM, Grund B, Law M, Losso MH, Palfreeman A, Wood R. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, et al. Among authors: palfreeman a. J Infect Dis. 2008 Apr 15;197(8):1133-44. doi: 10.1086/586713. J Infect Dis. 2008. PMID: 18476292 Clinical Trial.
Haemoglobin and anaemia in the SMART study.
Mocroft A, Lifson AR, Touloumi G, Neuhaus J, Fox Z, Palfreeman A, Vjecha MJ, Hodder S, De Wit S, Lundgren JD, Phillips AN; INSIGHT SMART Study Group. Mocroft A, et al. Among authors: palfreeman a. Antivir Ther. 2011;16(3):329-37. doi: 10.3851/IMP1746. Antivir Ther. 2011. PMID: 21555815 Free PMC article. Clinical Trial.
ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.
Sereti I, Gulick RM, Krishnan S, Migueles SA, Palfreeman A, Touzeau-Römer V, Belloso WH, Emery S, Law MG; INSIGHT START Study Group. Sereti I, et al. Among authors: palfreeman a. J Acquir Immune Defic Syndr. 2019 Aug 1;81(4):456-462. doi: 10.1097/QAI.0000000000002052. J Acquir Immune Defic Syndr. 2019. PMID: 31241541 Free PMC article. Clinical Trial.
Platelet count kinetics following interruption of antiretroviral treatment.
Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD; INSIGHT SMART Study Group. Zetterberg E, et al. Among authors: palfreeman a. AIDS. 2013 Jan 2;27(1):59-68. doi: 10.1097/QAD.0b013e32835a104d. AIDS. 2013. PMID: 23018440 Free PMC article. Clinical Trial.
Why START? Reflections that led to the conduct of this large long-term strategic HIV trial.
INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group; Lundgren J, Babiker A, Gordin F, Emery S, Fätkenheuer G, Molina JM, Wood R, Neaton JD. INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group, et al. HIV Med. 2015 Apr;16 Suppl 1(0 1):1-9. doi: 10.1111/hiv.12227. HIV Med. 2015. PMID: 25711317 Free PMC article. No abstract available.
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy.
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study. May MT, et al. Among authors: palfreeman a. AIDS. 2014 May 15;28(8):1193-202. doi: 10.1097/QAD.0000000000000243. AIDS. 2014. PMID: 24556869 Free PMC article.
155 results